F13.29
Sedative, hypnotic or anxiolytic dependence with unspecified sedative, hypnotic or anxiolytic-induced disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F13.29 describes a condition where an individual develops a dependence on sedatives, hypnotics, or anxiolytics, which are medications used to manage anxiety, promote sleep, or calm agitation. This classification indicates that the person has become reliant on these drugs, leading to potential health concerns, even if the specific drug or disorder type isn't clearly identified. Dependency on these substances can significantly impact daily living and overall well-being, highlighting the importance of understanding this condition.
Causes & Symptoms
Clinical Causes: Prolonged use of sedative, hypnotic, or anxiolytic medications beyond prescribed durations Self-medication to cope with stress, anxiety, or sleep disturbances History of mental health conditions such as anxiety or insomnia Genetic predisposition toward substance dependence Psychological factors like emotional distress or trauma Incorrect medication use, including dosage escalation without medical guidance
Key Symptoms: Craving the medication or a strong desire to use it Increased tolerance, requiring higher doses for the same effect Withdrawal symptoms such as anxiety, agitation, or sleep disturbances when not taking the drug Difficulty controlling or stopping medication intake Neglect of responsibilities and daily activities due to drug use Continued use despite negative health or social consequences
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive medical assessment, including a review of medication history, physical examination, and psychological evaluation. Healthcare providers may use standardized criteria to determine dependence. Blood tests or other investigations can help rule out other underlying causes for symptoms, while discussions about medication use help clarify the extent of dependency.
Treatment Protocols: Gradual tapering of the medication under medical supervision to reduce withdrawal risks Psychotherapeutic interventions such as cognitive-behavioral therapy (CBT) to address underlying issues Support groups or counseling to develop coping strategies Replacement therapies or alternative medications to manage anxiety or sleep issues safely Monitoring and follow-up to prevent relapse and address any emerging health concerns
Clinical Advice & FAQs
Billing Guidance
Is F13.29 a billable ICD-10 code?
Yes, F13.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.29?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence with unspecified sedative, hypnotic or anxiolytic-induced disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference